Literature DB >> 4560520

Cyanate as an inhibitor of red-cell sickling.

A Cerami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4560520     DOI： 10.1056/NEJM197210192871606

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation.

Authors:  D A Deiderich; R C Trueworthy; P Gill; A M Cader; W E Larsen
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

2.  Neurotoxicity of sodium cyanate. New pathological and ultrastructural observations in Maccaca nemestrina.

Authors:  I Tellez; D Johnson; R L Nagel; A Cerami
Journal:  Acta Neuropathol       Date:  1979-06-15       Impact factor: 17.088

3.  Anti-sickling effect of dietary thiocyanate in prophylactic control of sickle cell anemia.

Authors:  O Agbai
Journal:  J Natl Med Assoc       Date:  1986-11       Impact factor: 1.798

4.  Glutathione adducts, not carbamylated lysines, are the major modification of lens alpha-crystallins from renal failure patients.

Authors:  J B Smith; G A Shun-Shin; Y Sun; L R Miesbauer; Z Yang; Z Yang; X Zhou; J Schwedler; D L Smith
Journal:  J Protein Chem       Date:  1995-04

5.  Addition of multimodal therapy to standard management of steady state sickle cell disease.

Authors:  Iheanyi Okpala; Osita Ezenwosu; Anthony Ikefuna; Augustine Duru; Barth Chukwu; Anazoeze Madu; Theresa Nwagha; Sunday Ocheni; Obike Ibegbulam; Ifeoma Emodi; Uche Anike; Charles Nonyelu; Chukwudi Anigbo; Kingsley Agu; Ifeoma Ajuba; Awele Chukwura; Ogechukwu Ugwu; Uche Ololo
Journal:  ISRN Hematol       Date:  2013-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.